SEC Form 4 · accession 0001104659-15-016820
ARRAY BIOPHARMA INC · ARRY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kyle Lefkoff
Director
Period of report
Mar 3, 2015
Accepted (ET)
Mar 4, 2015 · 8:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100412
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 3, 2015 | M | 15,000 | $3.37 | A | 18,585 | D | |
| Common Stock | Mar 3, 2015 | M | 15,000 | $1.74 | A | 33,585 | D | |
| Common Stock | Mar 3, 2015 | M | 20,000 | $3.51 | A | 53,585 | D | |
| Common Stock | Mar 3, 2015 | M | 20,000 | $2.46 | A | 73,585 | D | |
| Common StockF1 | Mar 3, 2015 | S | 70,000 | $8.001 | D | 3,585 | D | |
| Common StockF2 | holding | — | — | — | 45,000 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF3 | $3.37 | Mar 3, 2015 | M | 15,000 | D | — | Dec 8, 2018 | Common Stock | 15,000 | 0 | D |
| Stock OptionF4 | $1.74 | Mar 3, 2015 | M | 15,000 | D | — | Oct 29, 2019 | Common Stock | 15,000 | 0 | D |
| Stock OptionF5 | $3.51 | Mar 3, 2015 | M | 20,000 | D | — | Nov 4, 2020 | Common Stock | 20,000 | 0 | D |
| Stock Option | $2.46 | Mar 3, 2015 | M | 20,000 | D | Oct 26, 2012 | Oct 26, 2022 | Common Stock | 20,000 | 0 | D |
Explanation of responses
- F1The price reflects the weighted average selling price for the 70,000 shares which were sold in the range of $8.00 to $8.01. Full information about the number of shares sold at each price is available upon request.
- F2Comprised of 30,000 shares of common stock in trust for the benefit of Mr. Lefkoff's minor children and 15,000 shares of common stock held by BV Partners III Profit Sharing account for the benefit of Mr. Lefkoff.
- F3The option vested in 3 equal annual installments beginning on November 1, 2009.
- F4The option vested in 3 equal annual installments beginning on November 1, 2010.
- F5The option vested in 3 equal annual installments beginning on November 4, 2011.